Jason Wasserman MD PhD FRCPC
August 1, 2024
Celiac disease is a medical condition where the body develops an abnormal reaction to gluten found in food. The abnormal reaction leads to inflammation which damages the tissue on the inner surface of the small bowel. The damage is caused by specialized immune cells called lymphocytes which are found in increased numbers in the small bowel of people with celiac disease. Another name for celiac disease is gluten-sensitive enteropathy.
Celiac disease can present with a wide range of symptoms that vary from person to person. Some individuals may have severe symptoms, while others may have mild or no symptoms. The symptoms can affect different parts of the body and may include:
Celiac disease is caused by an abnormal immune response to gluten, a protein found in wheat, barley, and rye. The exact cause of this immune response is not fully understood, but it involves a combination of genetic, environmental, and immunological factors.
A biopsy is usually performed because the patient has symptoms suggestive of celiac disease (gluten-sensitive enteropathy), which may include weakness and diarrhea. These symptoms occur when the patient eats food that contains gluten. Biopsies are usually taken from the 2nd part of the duodenum, where the changes associated with celiac disease are easiest to recognize.
A diagnosis of celiac disease (gluten-sensitive enteropathy) requires both clinical and pathological confirmation. Clinical confirmation is usually made by performing blood tests for antibodies that target tissue transglutaminase (anti-TTG), which is found in most patients with celiac disease.
When a pathologist examines a duodenum biopsy to assess for celiac disease, they look for specific microscopic features, including villous atrophy, villous blunting, crypt hyperplasia, and increased intraepithelial lymphocytes. These features help establish a diagnosis and assess the severity of the disease.
The duodenum is the first part of the small intestine and plays a crucial role in digestion and nutrient absorption. Under the microscope, a healthy duodenum shows:
A healthy duodenum has tall, finger-like villi, shallow crypts, and few IELs.
Villous atrophy is the flattening and loss of the normal finger-like projections (villi) lining the small intestine. Villous atrophy is seen in active celiac disease when the immune response to gluten causes significant damage to the intestinal lining. In partially treated celiac disease, villous atrophy may be less pronounced, with some regeneration of the villi occurring. Villi are crucial for nutrient absorption. Their atrophy reduces the surface area available for absorption, leading to malabsorption and nutrient deficiencies.
Villous blunting is a milder form of villous atrophy in which the villi are shortened but not completely flattened. It can be an early sign of celiac disease before full villous atrophy develops. In partially treated disease, villous blunting may improve, with villi becoming longer but not yet fully normal. This indicates an early or less severe form of mucosal damage compared to complete villous atrophy.
Crypt hyperplasia refers to the elongation and increased number of crypts, which are glands located at the base of the villi. Crypts normally produce new cells to replace the villi. In celiac disease, the crypts become larger and more numerous as the body attempts to regenerate the damaged mucosa, but this regeneration is ineffective due to ongoing inflammation.
Intraepithelial lymphocytes (IELs) are immune cells (a type of white blood cell) that infiltrate the epithelial layer of the intestine. A normal duodenum typically has fewer than 25 IELs per 100 enterocytes. In celiac disease, the number of IELs increases, often exceeding 25 per 100 enterocytes. Pathologists often describe this as intraepithelial lymphocytosis. Increased numbers of IELs are a hallmark of celiac disease and indicate an immune response to gluten in the diet.
The modified Marsh classification is a grading system used to describe the extent of mucosal damage in celiac disease. This classification system is useful for setting an initial baseline of disease activity and for assessing response to therapy and a gluten-free diet. It ranges from Marsh 0 to Marsh 3: